IL-17 homologous polypeptides and therapeutic uses thereof

Nucleic acid-enzyme complex

Emmprin antagonists and uses thereof

Dnazymes for Inhibition of Japanese Encephalitis Virus Replication

Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof

Treatment of HSV-related pathologies using plasmids that make ssDNA

CADHERIN-11-MEDIATED MODULATION OF HAIR GROWTH

Methods and Compositions for Treating 5Alpha-Reductase Type 1 and Type 2 Dependent Conditions

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Interleukin-15 antagonists for the treatment of anemia

CASPASE-8 INTERACTING PROTEINS

SHC proteins as therapeutic targets in proliferative diseases

Method of reducing CRF receptor mRNA

DNAzymes and sensors incorporating the same

Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a

Polycationic compositions for cellular delivery of polynucleotides

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

TREATMENT OF ALZHEIMER'S DISEASE WITH INHIBITORS OF APOE BINDING TO APOE RECEPTOR

Antisense compounds targeted to connexins and methods of use thereof

Multicomponent nucleic acid enzymes and methods for their use

RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)

Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)

Antisense IAP oligonucleotides and uses thereof

Antisense IAP oligonucleotides and uses thereof

Nucleic acid aptamer-based compositions and methods

Compositions and methods for modulating and monitoring neurotransmitter receptor populations

Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)

Regulation of food intake by modulation of long-chain fatty acyl-CoA levels in the hypothalamus

Shc proteins as therapeutic targets in proliferative diseases

Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)

GLUCOSE TRANSPORT-RELATED GENES, POLYPEPTIDES, AND METHODS OF USE THEREOF

Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies

DNA enzymes

Inhibition of hair growth with RNAi targeting desmoglein 4 and nude mRNAs

RNA interference compositions and methods

Methods and compositions for use in spliceosome mediated RNA trans-splicing

Synthesis, deprotection, analysis & purification of RNA & ribozymes

Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof

Antisense oligonucleotides targeting folate receptor alpha, and the use thereof

Enzymatic nucleic acid treatment of diseases or conditions related to levels of IKK-gamma and PKR

RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA)

Use of mob-5 in pain

RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA)

Effective and stable DNA enzymes

Desmoglein 4 is a novel gene involved in hair growth

Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases

Cks1 inhibitors

Methods and compositions for use in spliceosome mediated RNA trans-splicing in plants

Methods and materials for treating human papillomavirus infections

Combination therapies for cancer and proliferative angiopathies

Inhibition of tumor growth and invasion by anti-matrix metalloproteinase DNAzymes

RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)

Combinatorial methods and compositions for treatment of melanoma

RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA

Triplex hairpin ribozyme

RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)

Vascular therapeutics

Polycationic compositions for cellular delivery of polynucleotides

Osteoarthritis biomarkers and uses thereof

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)

RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)

VPS35-based assays and methods for treating Alzheimer's disease

RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of epidermal growth factor receptor (EGFR) gene expression using short interfering nucleic acid (siNA)

Bioreactive allosteric polynucleotides

RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of type 1 insulin-like growth factor receptor gene expression using short interfering nucleic acid (siNA)

Tissue adhesion formation control

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)

Self-cleaving ribozymes and uses thereof

RNA interference mediated inhibition of proliferating cell nuclear antigen (PCNA) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

DNA enzyme to inhibit plasminogen activator inhibitor-1

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)

RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of TRPM7 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)

Vascular therapeutics

RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)

Sp1 and Sp3 targeted cancer therapies and therapeutics

Tissue-specific and pathogen-specific ribozymes

Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Methods of treatment and compositions therefor

Bcl-2 dnazymes

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Method of reducing CRF receptor mRNA

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)

Gene amplification and overexpression in cancer

SHC proteins as therapeutic targets in proliferative diseases

Programmable alternative splicing devices and uses thereof